Jazz Pharmaceuticals (JAZZ) Change in Cash (2010 - 2026)

Jazz Pharmaceuticals' Change in Cash history runs 17 years deep, the most recent figure standing at $452.4 million for Q1 2026.

• In Q1 2026, Change in Cash rose 182.11% year-over-year to $452.4 million; the TTM figure through Mar 2026 stood at -$17.6 million (down 104.2% YoY), while the FY2025 annual figure was -$1.0 billion, down 212.62% from the prior year.
• Change in Cash was $452.4 million for Q1 2026 at Jazz Pharmaceuticals, up from $65.8 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $862.3 million in Q3 2024 to a low of -$672.0 million in Q2 2025.
• Historically, Change in Cash has averaged $73.7 million across 5 years, with a median of $114.4 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Change in Cash jumped 1515.28% in 2024, then sank 775.65% in 2025.
• A 5-year view of Change in Cash shows it stood at $42.1 million in 2022, then surged by 305.04% to $170.6 million in 2023, then increased by 14.13% to $194.7 million in 2024, then tumbled by 66.19% to $65.8 million in 2025, then surged by 587.24% to $452.4 million in 2026.
• The last three Change in Cash figures came in at $452.4 million (Q1 2026), $65.8 million (Q4 2025), and $136.2 million (Q3 2025), per Business Quant data.